Articles with "mibc" as a keyword



CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Immunology, Immunotherapy"

DOI: 10.1007/s00262-018-2250-9

Abstract: PurposeCD19+ tumor-infiltrating B-cells (CD19+ TIB) play a crucial role in tumorigenesis, but their clinical relevance in muscle-invasive bladder cancer (MIBC) remains unknown. This study aimed to investigate the prognostic value of CD19+ TIB for post-surgery… read more here.

Keywords: mibc; cd19; cd19 tib; cancer ... See more keywords
Photo by nci from unsplash

Clinical characterization of radiation-associated muscle-invasive bladder cancer.

Sign Up to like & get
recommendations!
Published in 2021 at "Urology"

DOI: 10.1016/j.urology.2021.03.033

Abstract: OBJECTIVE To characterize the presentation, patterns of care, and outcomes of radiation-associated muscle-invasive bladder cancer (RA-MIBC) compared to primary (non-radiation associated) MIBC. RA-MIBC has been suggested to represent a more aggressive disease variant and be… read more here.

Keywords: bladder cancer; mibc; compared primary; radiation associated ... See more keywords
Photo by cdc from unsplash

A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer.

Sign Up to like & get
recommendations!
Published in 2021 at "Scandinavian journal of urology"

DOI: 10.1080/21681805.2021.2002402

Abstract: PURPOSE To evaluate a method of transurethral visual response-staging in patients with urothelial muscle-invasive urinary bladder cancer (MIBC), undergoing neoadjuvant chemotherapy (NAC) and radical cystectomy (RC). METHODS A prospective study at four Swedish cystectomy centers,… read more here.

Keywords: mibc; response; cystoscopy; visual response ... See more keywords
Photo by nci from unsplash

Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment

Sign Up to like & get
recommendations!
Published in 2022 at "Scandinavian Journal of Urology"

DOI: 10.1080/21681805.2022.2056633

Abstract: Abstract Purpose To assess if cancer-specific survival (CSS) following curative intent treatment (CIT) for muscle-invasive bladder cancer (MIBC) differs between patients presenting with MIBC (primary) and patients presenting with non-muscle-invasive bladder cancer who progress to… read more here.

Keywords: bladder cancer; cancer; mibc; muscle invasive ... See more keywords
Photo from wikipedia

Abstract 2509: Similar variant histology and immune cell infiltration in canine and human muscle-invasive bladder cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-2509

Abstract: Introduction: Muscle-Invasive Bladder Cancer (MIBC) is associated with a poor overall survival rate. One important factor that contributes to poor treatment outcomes is the histologic heterogeneity of MIBC tumors, which limits the translational value of… read more here.

Keywords: immune cell; canine; histology; cancer ... See more keywords
Photo from wikipedia

Abstract 768: Immunohistochemistry analysis of the molecular subtypes of muscle invasive bladder cancer in association with prognosis

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-768

Abstract: Background: Bladder cancer (BC) is one of the most common cancers worldwide. Muscle invasion BC (MIBC) has a poor prognosis and is usually in an advanced stage. Recently, whole genome sequencing research in BC has… read more here.

Keywords: molecular subtypes; prognosis; basal; association ... See more keywords
Photo by nci from unsplash

Abstract PR18: Somatic ERCC2 mutations, nucleotide excision repair (NER) function, and cisplatin response in muscle-invasive bladder cancer (MIBC)

Sign Up to like & get
recommendations!
Published in 2017 at "Molecular Cancer Research"

DOI: 10.1158/1557-3125.dnarepair16-pr18

Abstract: ERCC2 is a core member of the nucleotide excision repair (NER) pathway, a highly conserved and remarkably versatile DNA repair pathway responsible for repairing intrastrand DNA adducts created by genotoxic agents such as UV irradiation… read more here.

Keywords: mibc; response; cancer; ercc2 mutations ... See more keywords
Photo by nci from unsplash

Prognostic significance of history of nonmuscle invasive bladder cancer in patients with muscle invasive bladder cancer treated with neoadjuvant chemotherapy followed by surgery.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.7_suppl.375

Abstract: 375 Background: Efficacy of cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) for T2-4aN1M0 muscle-invasive bladder cancer (MIBC) was proved by randomize controlled trials. Recent retrospective studies suggested that MIBC patients who had a… read more here.

Keywords: invasive bladder; bladder cancer; secondary mibc; mibc ... See more keywords
Photo from wikipedia

Impact of Aurora kinase A and B expression on response to neoadjuvant chemotherapy and patient outcome in muscle-invasive bladder cancer (MIBC).

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.7_suppl.393

Abstract: 393 Background: Identification of robust biomarkers that predict likelihood of benefit from neoadjuvant chemotherapy (NAC) in patients with MIBC remains an unmet need. Previous studies have implicated tumor overexpression of aurora kinases A (AURKA) and… read more here.

Keywords: expression; aurka aurkb; tumor; mibc ... See more keywords
Photo by nci from unsplash

Phase III study of pembrolizumab (pembro) plus chemoradiotherapy (CRT) versus CRT alone for patients (pts) with muscle-invasive bladder cancer (MIBC): KEYNOTE-992.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.tps5093

Abstract: TPS5093Background: Pembro has shown clinical activity across many stages of bladder cancer (BC), including metastatic BC, MIBC, and NMIBC. Current NCCN and AUA/ASCO/ASTRO/SUO guidelines recommend C... read more here.

Keywords: bladder cancer; mibc; phase iii; iii study ... See more keywords
Photo by nci from unsplash

Development of a composite biomarker-based calculator to predict the probability of pathologic complete response (pT0) after neoadjuvant pembrolizumab (pembro) in muscle invasive bladder cancer (MIBC).

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.6_suppl.539

Abstract: 539Background: The PURE01 study (NCT02736266) evaluates the use of pembro before radical cystectomy (RC) in MIBC. We assessed selected individual and combined biomarkers for predicting pT0 response... read more here.

Keywords: development composite; composite biomarker; mibc; based calculator ... See more keywords